Navigation Links
Influenza pandemic planning needed to assure adequate care for pregnant women and newborns
Date:5/13/2009

PITTSBURGH, May 13 Pregnant women and newborns are at greatest risk in a flu epidemic, but more planning must be done to ensure that they receive priority treatment should an outbreak occur, according to a University of Pittsburgh Medical Center (UPMC) and University of Pittsburgh study. The findings, published online in Emerging Health Threats Journal, raise concerns about the ability of hospitals to adequately treat this vulnerable population, particularly in light of the current H1N1 flu outbreak.

"Although it is not clear how well modern medicine will be able to prevent devastation during a large-scale infectious disease outbreak, it is widely recognized that advance planning may lessen the negative impact," said study author Richard Beigi, M.D., Department of Obstetrics, Gynecology and Reproductive Sciences at Magee-Womens Hospital of UPMC. "This is especially important for pregnant women, fetuses and neonates, all of whom are often left out of national level consideration."

The study was based on an Internet survey of the 12-member Council of Women's and Infants' Specialty Hospitals, a national organization of non-profits that share information and operational data to improve maternity and newborn care. Member hospitals account for over 120,000 deliveries annually. Seven of the nine are free-standing maternity hospitals and the other two are maternity hospitals within large health systems.

"A major concern we found was how to ethically ration limited medical resources when faced with too many patients and not enough medical supplies and personnel," said Dr. Beigi, who is an assistant professor in the Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Infectious Diseases and Immunology, University of Pittsburgh School of Medicine.

He added, "Although 56 percent of hospitals report that they have begun to address this issue, none have any formal plan yet in place. Another complicating factor is that despite the likelihood that this population will have an increased susceptibility to influenza during a pandemic, little data exist on the safety of vaccines and treatments to combat infectious disease in pregnant women and newborns."

The encouraging news is that 78 percent of the hospitals that responded have formal written plans in place to address communications, a surge in patient volume and possible degradation of non-essential medical services. All facilities planned to provide care to their own employees despite the potential for significant shortages of both personnel and supplies, and 56 percent of the hospitals planned to provide augmented day-care services for employees' children to help workers continue to work.

An additional area of concern is coordination with local, state and federal government public health agencies. Many hospitals, particularly private ones, are uncertain how they would interact with public health agencies.

Still, public health agencies will play a critical role in providing information, medications and vaccine dissemination since they will be supplied by the federal strategic stockpile and may have the most accurate information as a pandemic unfolds, Dr. Beigi reported.

Although it is difficult to predict when the next influenza pandemic will occur, large scale outbreaks have been reported every 10 to 40 years. The emergence of H5N1 avian influenza in 1997 and the fact that nearly 40 years have passed since the last outbreak makes the threat of a severe pandemic a realistic possibility in the near future.

"Many challenges remain if we are to improve on our efforts to optimize outcomes for pregnant women and newborns during the next influenza pandemic," he said. "It is hoped that this study will stimulate planning efforts for all hospitals providing maternity care in preparation for this apparently inevitable infectious disease outbreak."


'/>"/>

Contact: Frank Raczkiewicz
RaczkiewiczFA@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
2. U.S. FDA Licenses Sanofi Pasteurs New Influenza Vaccine Manufacturing Facility
3. Simcere Pharmaceutical Group Seeking Approval to Manufacture and Sell Influenza Drug zanamivir
4. InDevRs FluChip detects and distinguishes swine-origin H1N1 from human influenza viruses
5. Midwest Research Institute Selected to Help Companies Advance the Development of Influenza Vaccines
6. Belize Takes Further Action Regarding Influenza A (H1N1) to Ensure Safety of Travelers
7. GlaxoSmithKline Update: Influenza A (H1N1)
8. Natural Killer Cells May Help Protect Against New Strains of Influenza Virus
9. EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus
10. Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Todays Health Professionals
11. Union Survey on Influenza Pandemic Finds Lack of Adequate Health and Safety Measures for Health Care Workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: